WallStreetZenWallStreetZen

NASDAQ: ONTX
Onconova Therapeutics Inc Stock Ownership - Who owns Onconova Therapeutics?

Insider buying vs selling

Have Onconova Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark Patrick GuerinCFO AND COO2024-03-142,591$0.90
$2.33kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-03-148,727$0.90
$7.85kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-02-079,212$0.67
$6.17kSell
Mark Patrick GuerinCFO AND COO2024-02-072,443$0.67
$1.64kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2023-08-034,744$1.01
$4.79kSell
Mark Patrick GuerinCFO AND COO2023-08-031,422$1.02
$1.45kSell
Mark Patrick GuerinCFO AND COO2023-06-121,575$1.14
$1.79kSell

1 of 1

ONTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONTX insiders and whales buy or sell their stock.

ONTX Shareholders

What type of owners hold Onconova Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman32.91%6,911,786$6.70MInsider
Jane Hoffman 2013 Descendants Michael21.51%4,518,275$4.38MInsider
Gmbh Baxalta12.39%2,603,295$2.53MInsider
Armistice Capital LLC7.87%1,653,902$1.60MInsider
Vanguard Group Inc3.37%708,618$687.36kInstitution
Tyndall Capital Partners L P2.93%616,389$597.90kInsider
683 Capital Management LLC2.19%460,000$446.20kInsider
Viren Mehta1.20%252,700$245.12kInsider
Ramesh Kumar1.20%252,264$244.70kInsider
Blackrock Inc1.18%248,881$241.41kInstitution

1 of 3

ONTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONTX7.94%83.99%Net SellingNet Selling
GLTO14.20%24.86%Net Selling
BIVI3.67%96.33%Net Selling
SYBX3.98%96.02%Net Selling
PHGE17.65%57.82%Net Buying

Onconova Therapeutics Stock Ownership FAQ

Who owns Onconova Therapeutics?

Onconova Therapeutics (NASDAQ: ONTX) is owned by 7.94% institutional shareholders, 83.99% Onconova Therapeutics insiders, and 8.07% retail investors. Michael B. Hoffman is the largest individual Onconova Therapeutics shareholder, owning 6.91M shares representing 32.91% of the company. Michael B. Hoffman's Onconova Therapeutics shares are currently valued at $6.98M.

If you're new to stock investing, here's how to buy Onconova Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.